ENVISION NEXUS
Live / Registered — Registered (as of 20 Feb 2024)
What this means for you
Registered since 20 Feb 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Feb 2030: the §8 declaration of use).
Record
- Serial number
- 97186776
- Registration number
- 7311127
- Mark type
- Word mark
- Filed
- 23 Dec 2021
- Published for opposition
- 06 Jun 2023
- Registered
- 20 Feb 2024
- Next maintenance filing
- §8 declaration of use, due by 20 Feb 2030 (grace period to 20 Aug 2030)
- Attorney of record
- Kevin Oliver
Goods and services
- Class 009 — Scientific and electric apparatus: Apparatus and instruments for research in pharmaceutical and academic laboratories for drug discovery and high throughput screening, and for analysis of microplate based assays, namely, plate readers, instruments for measuring absorbance, fluorescence intensity, luminescence, time-resolved fluorescence or fluorescence polarization
Owner
- REVVITY SINGAPORE PTE. LTD., SINGAPORE, SG
- REVVITY SINGAPORE PTE. LTD., SINGAPORE, SG
- PerkinElmer Singapore Pte Ltd., Singapore, SG
- PerkinElmer Singapore Pte Ltd., Singapore, SG
Prior registrations
Prosecution history
- 20 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2023 — USE AMENDMENT FILED
- 12 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 16 Aug 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Aug 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jun 2023 — PUBLISHED FOR OPPOSITION
- 17 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED